Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Moosbauer
An Exploratory Study of Systemic Administration of the Toll-Like Receptor-7 Agonist 852A in Patients With Refractory Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Related publications
A Single and Multiple Ascending Dose Study of Toll-Like Receptor 7 (TLR 7) Agonist (RO7020531) in Chinese Healthy Volunteers
Clinical and Translational Science
Genetics
Molecular Biology
Pharmacology
Biochemistry
Neuroscience
Medicine
Toxicology
Pharmaceutics
Toll-Like Receptor 7/8 Agonist Resiquimod Induces Late Preconditioning in Neonatal Cardiac Myocytes
Acta Pharmacologica Sinica
Medicine
Pharmacology
Pilot Study of Intratumoral G100, Toll-Like Receptor-4 (TLR4) Agonist, Therapy in Patients With Merkel Cell Carcinoma (MCC).
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Reduction of Voluntary Physical Activity in Mice Induced by Toll-Like Receptor 7 Agonist R-848
The Journal of Physical Fitness and Sports Medicine
Pharmacokinetic-Pharmacodynamic Modeling of Alpha Interferon Response Induced by a Toll-Like 7 Receptor Agonist in Mice
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees
Gastroenterology
Hepatology
Gastroenterology
The Toll-Like Receptor 4 Agonist Monophosphoryl Lipid a Augments Innate Host Resistance to Systemic Bacterial Infection
Infection and Immunity
Parasitology
Infectious Diseases
Immunology
Microbiology
Toll-Like-Rezeptro-7-Agonist Imiquimod (AldaraTM): Ein Topischer Immunmodulator
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
Toll-Like Receptor 4 Polymorphisms in Patients With Stargardt Disease: A Family Study
Revista Mexicana de Oftalmología (English Edition)